Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors

Lizza E. L. Hendriks*, Gerben Bootsma, Jean Mourlanette, Clemence Henon, Laura Mezquita, Roberto Ferrara, Clarisse Audigier-Valette, Julien Mazieres, Corentin Lefebvre, Boris Duchemann, Sophie Cousin, Cecile le Pechoux, Angela Botticella, Dirk De Ruysscher, Anne-Marie C. Dingemans, Benjamin Besse

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

28 Downloads (Pure)
Original languageEnglish
Pages (from-to)182-189
Number of pages8
JournalEuropean Journal of Cancer
Volume116
DOIs
Publication statusPublished - Jul 2019

Keywords

  • NSCLC
  • Immune checkpoint inhibition
  • Leptomeningeal metastases
  • NIVOLUMAB

Cite this